Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ECGFpro2 + Heparin (complete for lymphatic ECs)

Produktnummer ABIN1589777
  • Target
    ECGFpro2
    Reaktivität
    Rind (Kuh)
    Wirt
    Cow
    Applikation
    Cell Culture (CC)
    Kreuzreaktivität
    Human, Maus
    Produktmerkmale
    Chromosomal location: 5q31
  • Applikationshinweise
    Optimum concentration for human umbilical vein endothelial cells (HUVEC) range from 50-200 µg/mL, optimal concentration with heparin (50 µg/mL) is about 12 µg/mL.
    Kommentare

    Supplements

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Reconstitute the contents of the vial in 2 ml of prewarmed (37 °C) sterile PBS or water. Gently rotate the vial until the contents are dissolved. This stock solution may be further diluted in sterile tissue culture media to obtain the desired working concentrations. It is recommended that medium containing diluted product is aseptically filtered prior to use.
    Buffer
    water, 2.5 mg Heparin/mg ECGF, rh-VEGF-C (final concentration: 50 ng/mL)
    Lagerung
    4 °C
    Informationen zur Lagerung
    Also stable at 4 °C for several weeks it is recommended to store the product below 0 °C. After reconstitution the product shout be stored in aliquots at -20 °C to -70 °C.
  • Target
    ECGFpro2
    Hintergrund
    Endothelial cell growth factor (ECGF) is an extract of bovine brain containing growth promoting factors for vascular endothelial cells of mammalian origin. Endothelial cell growth factor is prepared using a modification of the method of Maciag, et al. (1979) lyophilized from a sterile solution containing NaCl and streptomycin sulfate. ECGFpro2 is supplemented with recombinant human VEGF-C (corresponding to 50 ng/ml) a concentration sufficient for the cultivation of lymphatic endothelial cells. Lymphatic endothelial cells from human skin can be established as primary cultures by traditional methods. The serial propagation of these cells has proved to be difficult. The long-term propagation of these cells in vitro can be achieved with an extract prepared from bovine brain. The introduction of a fibronectin or collagen matrix to the cell culture system allows cultivating endothelial cells at clonal densities. With ECGF, the FCS requirement can be reduced. Heparin potentiates the mitogenic activity of crude preparations of ECGF. ECGF has also been reported to eliminate the need for feeder cells in the clonal growth of hybridomas and other cell types.
    Synonyms: Endothelial cell growth factor (ECGF), Endothelial cell growth supplement (ECGS)
Sie sind hier:
Kundenservice